Published Date: 10 Mar 2023
This decision will ensure that effective drugs are available in all communities, and state pharmacies must:
Read Full NewsPrograms offering telehealth counseling and nicotine replacement products should be part of routine oncology care, researchers say.
Researchers evaluate minimal residual disease status in 128 adults with relapsed or refractory follicular lymphoma treated with epcoritamab.
A new study explores whether germline profiling could refine the subclassification and prognosis of therapy-related myeloid neoplasms beyond treatment history alone.
1.
Mapping lifelong chronic health risks for childhood cancer survivors
2.
High Fruit, Veggie Diet Tied to Early-Onset Lung Cancer?
3.
Avoiding Neuropathy From Chemo; Predictive Value of Screening EKGs
4.
Coffee, Tea Tied to Lower Risk of Head and Neck Cancer
5.
MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC
1.
Target-Mediated Drug Disposition in Hematologic Therapeutics
2.
Unlocking the Potential of Polatuzumab for Cancer Treatment
3.
Unlocking the Unknown: A Comprehensive Guide to Stage 4 Vulvar Cancer
4.
An Overview Of Leukemia Cutis: What It Is And How To Treat It
5.
The benefits and risks of taking fludrocortisone for adrenal insufficiency
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
2.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
5.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation